You are here

Blueprint Medicines

Winners and Losers From the Biggest Cancer Meeting of the Year (So Far)

Winners and Losers From the Biggest Cancer Meeting of the Year (So Far)

Motley Fool

Blueprint Medicines

Nektar Therapeutics

Jounce Therapeutics

Flag link:

Alexion leaves Moderna, others behind in R&D shake-up

Alexion leaves Moderna, others behind in R&D shake-up

BioPharma Dive

Moderna Therapeutics

Arbutus BioPharma

Blueprint Medicines

Flag link:

Blueprint plots a $100M IPO for its precision medicine platform

Blueprint plots a $100M IPO for its precision medicine platform

Fierce Biotech

Blueprint Medicines

Flag link:

Alexion bets up to $265M on Blueprint's precision medicine platform

Alexion bets up to $265M on Blueprint's precision medicine platform

Fierce Biotech

precision medicine

Blueprint Medicines

Flag link:

FierceBiotech's 2011 Fierce 15 Biotech Companies

FierceBiotech's 2011 Fierce 15 Biotech Companies

Fierce Biotech

Blueprint Medicines

Cerenis Therapeutics

Forma Therapeutics

Merrimack Pharmaceuticals

Pearl Therapeutics

Rib-X Pharmaceuticals

Flag link: